Skip to main content
Top
Published in: Surgical and Radiologic Anatomy 7/2018

01-07-2018 | Anatomic Bases of Medical, Radiological and Surgical Techniques

Clinical evaluation of the aberrant left hepatic artery arising from the left gastric artery in esophagectomy

Authors: Harufumi Maki, Hitoshi Satodate, Shouichi Satou, Kentaro Nakajima, Atsuki Nagao, Kazuteru Watanabe, Satoshi Nara, Kaoru Furushima, Yasushi Harihara

Published in: Surgical and Radiologic Anatomy | Issue 7/2018

Login to get access

Abstract

Purpose

The left gastric artery (LGA) is commonly severed when the gastric tube is made for esophageal reconstruction. Sacrifice of the LGA can cause liver ischemic necrosis in patients with an aberrant left hepatic artery (ALHA) arising from the LGA. We experienced a case of life-threatening hepatic abscess after severing the ALHA. Therefore, the purpose of this study is to evaluate clinical outcomes of severing the ALHA.

Methods

We retrospectively enrolled 176 consecutive patients who underwent esophagectomy with gastric tube reconstruction. They were classified into the ALHA (N = 16, 9.1%) and non-ALHA (N = 160, 90.9%) groups. Univariate analysis was performed to compare the clinicopathological variables. Long-term survival was analyzed using the Kaplan–Meier method in matched pair case–control analysis.

Results

The postoperative morbidities were not statistically different between the two groups, although serum alanine aminotransferase levels on postoperative days 1 and 3 were significantly higher in the ALHA group (36 IU/L, 14–515; 32 IU/L, 13–295) than in the non-ALHA group (24 IU/L, 8–163; 19 IU/L, 6–180), respectively (p = 0.0055; p = 0.0073). Overall survival was not statistically different between the two groups (p = 0.26).

Conclusions

Severe hepatic abscess occurred in 6.3% of the patients with the ALHA after esophagectomy, even though the results presented here found no statistical differences in morbidity or mortality with or without the ALHA. Surgeons should probably attempt to preserve the ALHA especially in patients with altered liver function while making a gastric tube for esophageal reconstruction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Backemar L, Lagergren P, Johar A, Lagergren J (2015) Impact of co-morbidity on mortality after oesophageal cancer surgery. Br J Surg 102:1097–1105CrossRefPubMed Backemar L, Lagergren P, Johar A, Lagergren J (2015) Impact of co-morbidity on mortality after oesophageal cancer surgery. Br J Surg 102:1097–1105CrossRefPubMed
2.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
3.
go back to reference Hemming AW, Finley RJ, Evans KG, Nelems B, Fradet G (1992) Esophagogastrectomy and the variant left hepatic artery. Ann Thorac Surg 54:166–168CrossRefPubMed Hemming AW, Finley RJ, Evans KG, Nelems B, Fradet G (1992) Esophagogastrectomy and the variant left hepatic artery. Ann Thorac Surg 54:166–168CrossRefPubMed
5.
go back to reference Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW et al (2013) Short-term clinical implications of the accessory left hepatic artery in patients undergoing radical gastrectomy for gastric cancer. PLoS One 8(5):e64300CrossRefPubMedPubMedCentral Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW et al (2013) Short-term clinical implications of the accessory left hepatic artery in patients undergoing radical gastrectomy for gastric cancer. PLoS One 8(5):e64300CrossRefPubMedPubMedCentral
6.
go back to reference Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48:452–458CrossRef Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48:452–458CrossRef
7.
go back to reference Kanehara & Co., Ltd (2008) Japanese Society of Esophageal Diseases. Japnanese Classification of Esophageal Cancer (Tenth Edition) Tokyo Kanehara & Co., Ltd (2008) Japanese Society of Esophageal Diseases. Japnanese Classification of Esophageal Cancer (Tenth Edition) Tokyo
8.
go back to reference Kim J, Kim SM, Seo JE, Ha MH, An JY, Choi MG et al (2016) Should an aberrant left hepatic artery arising from the left gastric artery be preserved during laparoscopic gastrectomy for early gastric cancer treatment? J Gastric Cancer 16(2):72–77CrossRefPubMedPubMedCentral Kim J, Kim SM, Seo JE, Ha MH, An JY, Choi MG et al (2016) Should an aberrant left hepatic artery arising from the left gastric artery be preserved during laparoscopic gastrectomy for early gastric cancer treatment? J Gastric Cancer 16(2):72–77CrossRefPubMedPubMedCentral
10.
go back to reference Lurie AS (1987) The significance of the variant left accessory hepatic artery in surgery for proximal gastric cancer. Arch Surg 122:725–728CrossRefPubMed Lurie AS (1987) The significance of the variant left accessory hepatic artery in surgery for proximal gastric cancer. Arch Surg 122:725–728CrossRefPubMed
11.
12.
go back to reference Mays ET, Wheeler CS (1974) Demonstration of collateral arterial flow after interruption of hepatic arteries in man. N Engl J Med 290:993–996CrossRefPubMed Mays ET, Wheeler CS (1974) Demonstration of collateral arterial flow after interruption of hepatic arteries in man. N Engl J Med 290:993–996CrossRefPubMed
14.
go back to reference Okano S, Sawai K, Taniguchi H, Takahashi T (1993) Aberrant left hepatic artery arising from the left gastric artery and liver function after radical gastrectomy for gastric cancer. World J Surg 17:70–73 (discussion 4)CrossRefPubMed Okano S, Sawai K, Taniguchi H, Takahashi T (1993) Aberrant left hepatic artery arising from the left gastric artery and liver function after radical gastrectomy for gastric cancer. World J Surg 17:70–73 (discussion 4)CrossRefPubMed
15.
go back to reference Oki E, Sakaguchi Y, Hiroshige S, Kusumoto T, Kakeji Y, Maehara Y (2011) Preservation of an aberrant hepatic artery arising from the left gastric artery during laparoscopic gastrectomy for gastric cancer. J Am Coll Surg 212:e25–e7CrossRef Oki E, Sakaguchi Y, Hiroshige S, Kusumoto T, Kakeji Y, Maehara Y (2011) Preservation of an aberrant hepatic artery arising from the left gastric artery during laparoscopic gastrectomy for gastric cancer. J Am Coll Surg 212:e25–e7CrossRef
16.
go back to reference Randjelovic DT, Filipovic RB, Bilanovic LD, Stanisavljevic SN (2007) Perigastric vascular abnormalities and the impact on esophagogastrectomy. Dis Esophagus 20:390–398CrossRefPubMed Randjelovic DT, Filipovic RB, Bilanovic LD, Stanisavljevic SN (2007) Perigastric vascular abnormalities and the impact on esophagogastrectomy. Dis Esophagus 20:390–398CrossRefPubMed
17.
go back to reference Shinohara T, Ohyama S, Muto T, Yanaga K, Yamaguchi T (2007) The significance of the aberrant left hepatic artery arising from the left gastric artery at curative gastrectomy for gastric cancer. Eur J Surg Oncol 33:967–971CrossRefPubMed Shinohara T, Ohyama S, Muto T, Yanaga K, Yamaguchi T (2007) The significance of the aberrant left hepatic artery arising from the left gastric artery at curative gastrectomy for gastric cancer. Eur J Surg Oncol 33:967–971CrossRefPubMed
18.
go back to reference Sohda M, Kuwano H (2017) Current status and future prospects for esophageal cancer treatment. Ann Thorac Cardiovasc Surg 23:1–11CrossRefPubMed Sohda M, Kuwano H (2017) Current status and future prospects for esophageal cancer treatment. Ann Thorac Cardiovasc Surg 23:1–11CrossRefPubMed
19.
go back to reference Valmasoni M, Pierobon ES, De Pasqual CA, Zanchettin G, Moletta L, Salvador R et al (2017) Esophageal cancer surgery for patients with concomitant liver cirrhosis: a single-center matched-cohort study. Ann Surg Oncol 24(3):763–769CrossRefPubMed Valmasoni M, Pierobon ES, De Pasqual CA, Zanchettin G, Moletta L, Salvador R et al (2017) Esophageal cancer surgery for patients with concomitant liver cirrhosis: a single-center matched-cohort study. Ann Surg Oncol 24(3):763–769CrossRefPubMed
20.
go back to reference Yasuda M, Saeki H, Nakashima Y, Yukaya T, Tsutsumi S, Tajiri H et al (2015) Treatment results of two-stage operation for the patients with esophageal cancer concomitant with liver dysfunction. J Med Invest 62(3–4):149–153CrossRefPubMed Yasuda M, Saeki H, Nakashima Y, Yukaya T, Tsutsumi S, Tajiri H et al (2015) Treatment results of two-stage operation for the patients with esophageal cancer concomitant with liver dysfunction. J Med Invest 62(3–4):149–153CrossRefPubMed
21.
go back to reference Zhang W, Yu D, Peng J, Xu J, Wei Y (2017) Gastric-tube versus whole-stomach esophagectomy for esophageal cancer: a systematic review and meta-analysis. PLoS One 12:e0173416CrossRefPubMedPubMedCentral Zhang W, Yu D, Peng J, Xu J, Wei Y (2017) Gastric-tube versus whole-stomach esophagectomy for esophageal cancer: a systematic review and meta-analysis. PLoS One 12:e0173416CrossRefPubMedPubMedCentral
Metadata
Title
Clinical evaluation of the aberrant left hepatic artery arising from the left gastric artery in esophagectomy
Authors
Harufumi Maki
Hitoshi Satodate
Shouichi Satou
Kentaro Nakajima
Atsuki Nagao
Kazuteru Watanabe
Satoshi Nara
Kaoru Furushima
Yasushi Harihara
Publication date
01-07-2018
Publisher
Springer Paris
Published in
Surgical and Radiologic Anatomy / Issue 7/2018
Print ISSN: 0930-1038
Electronic ISSN: 1279-8517
DOI
https://doi.org/10.1007/s00276-018-2022-4

Other articles of this Issue 7/2018

Surgical and Radiologic Anatomy 7/2018 Go to the issue